These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6494585)

  • 41. In vitro studies of canine mammary tumors: influence of 17-beta-estradiol and progesterone on cell kinetics parameters.
    Lespagnard L; Kiss R; Danguy A; Legros N; Lenglet G; Devleeschouwer N; Paridaens R
    Oncology; 1987; 44(5):292-301. PubMed ID: 3670796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen and oncogene mediated growth regulation of human breast cancer cells.
    Kasid A; Lippman ME
    J Steroid Biochem; 1987; 27(1-3):465-70. PubMed ID: 3501040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects and mechanism of action of antiestrogens in breast cancer].
    Borgna JL; Rochefort H
    Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acetaminophen-induced proliferation of breast cancer cells involves estrogen receptors.
    Harnagea-Theophilus E; Gadd SL; Knight-Trent AH; DeGeorge GL; Miller MR
    Toxicol Appl Pharmacol; 1999 Mar; 155(3):273-9. PubMed ID: 10079213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progestin effects on growth in the human breast cancer cell line T-47D--possible therapeutic implications.
    Hissom JR; Moore MR
    Biochem Biophys Res Commun; 1987 Jun; 145(2):706-11. PubMed ID: 3593365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.
    Eckert RL; Katzenellenbogen BS
    Cancer Res; 1982 Jan; 42(1):139-44. PubMed ID: 7053842
    [No Abstract]   [Full Text] [Related]  

  • 47. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro.
    Danforth DN; Sgagias MK
    Cancer Res; 1991 Mar; 51(5):1488-93. PubMed ID: 1997187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of progesterone receptor in an estrogen, progesterone receptor-negative breast cancer cell line.
    Devleeschouwer N; Olea-Serrano N; Leclercq G; Legros N; Heuson JC
    J Steroid Biochem; 1986 Jan; 24(1):365-8. PubMed ID: 3702420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hormones and breast cancer in vitro.
    Dickson RB; Thompson EW; Lippman ME
    Hum Cell; 1989 Sep; 2(3):219-30. PubMed ID: 2519209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line.
    Barrón-González A; Castro Romero I
    Biochem Cell Biol; 2004 Apr; 82(2):335-42. PubMed ID: 15060629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a point mutation in the hormone binding domain of the estrogen receptor from an breast tumor.
    England GM; Bilimoria MM; Chen Z; Assikis VJ; Muenzner HD; Jordan VC
    Int J Oncol; 1998 May; 12(5):981-6. PubMed ID: 9538117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of breast tumor growth by high dose estrogen is independent of the presence of estrogen receptors.
    Hug V; Drewinko B; Hortobagyi GN; Blumenschein G
    Breast Cancer Res Treat; 1985; 6(3):237-40. PubMed ID: 4092099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparative study of three antiestrogens in MCF-7 and ZR-75-1 human breast cancer cells].
    Kurebayashi J; Aoyagi H; Iino Y; Ishida T; Izuo M; Horiuchi R; Takikawa H
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2575-83. PubMed ID: 2974858
    [No Abstract]   [Full Text] [Related]  

  • 54. Analogies and differences in the modulation of progesterone receptor induction and cell proliferation by estrogens and antiestrogens in MCF-7 human breast cancer cells: study with 24 triphenylacrylonitrile derivatives.
    Bignon E; Pons M; Gilbert J; Crastes de Paulet A
    J Steroid Biochem; 1988 Dec; 31(6):877-85. PubMed ID: 3199824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens.
    Thompson EW; Reich R; Shima TB; Albini A; Graf J; Martin GR; Dickson RB; Lippman ME
    Cancer Res; 1988 Dec; 48(23):6764-8. PubMed ID: 2846159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.
    Masamura S; Santner SJ; Heitjan DF; Santen RJ
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2918-25. PubMed ID: 7559875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steroidal and nonsteroidal antiestrogens in breast cancer cells in culture.
    Rochefort H; Bardon S; Chalbos D; Vignon F
    J Steroid Biochem; 1984 Jan; 20(1):105-10. PubMed ID: 6368983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
    Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
    Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a marker of estrogenic exposure in breast cancer patients.
    Pazos P; Pérez P; Rivas A; Nieto R; Botella B; Crespo J; Olea-Serrano F; Fernández MF; Expósito J; Olea N; Pedraza V
    Adv Exp Med Biol; 1998; 444():29-40. PubMed ID: 10026931
    [No Abstract]   [Full Text] [Related]  

  • 60. Reduction of the anti-metabolic and anti-proliferative effects of methotrexate by 17 beta-oestradiol in a human breast carcinoma cell line, MDA-MB-436.
    Clarke R; Van den Berg HW; Kennedy DG; Murphy RF
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):19-24. PubMed ID: 6682774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.